New Data Evaluating Laquinimod for the Treatment of Multiple Sclerosis Demonstrate Neuroprotective Effects
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that dat…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that dat…
. - Enhanced levels of brain derived neurotrophic factor, possibly contributing to neuroprotection, were shown in laqui…
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced that several new studies supporting the company's inn…
4SC AG (Frankfurt, Prime Standard: VSC) the German drug discovery and development company, today announced that it will…
Arpida Ltd (SWX: ARPN) presented several posters containing clinical data on its late-stage investigational antibiotic i…